Humana (HUM) Notes Payables (2009 - 2026)

Humana's Notes Payables history runs 18 years deep, the most recent figure standing at $297.0 million for Q1 2026.

• In Q1 2026, Notes Payables fell 19.73% year-over-year to $297.0 million; the TTM figure through Mar 2026 stood at $297.0 million (down 19.73% YoY), while the FY2025 annual figure was $306.0 million, down 24.07% from the prior year.
• Notes Payables was $297.0 million for Q1 2026 at Humana, down from $306.0 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $457.0 million in Q2 2023 to a low of $237.0 million in Q3 2022.
• Historically, Notes Payables has averaged $337.1 million across 5 years, with a median of $333.0 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Notes Payables surged 65.68% in 2022, then decreased 24.07% in 2025.
• A 5-year view of Notes Payables shows it stood at $298.0 million in 2022, then grew by 18.46% to $353.0 million in 2023, then grew by 14.16% to $403.0 million in 2024, then decreased by 24.07% to $306.0 million in 2025, then dropped by 2.94% to $297.0 million in 2026.
• The last three Notes Payables figures came in at $297.0 million (Q1 2026), $306.0 million (Q4 2025), and $308.0 million (Q3 2025), per Business Quant data.